Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ACR | Ann: Investor Presentation | 19/03/19 | 11 | 6.4K | |||
|
|||||||
ACR | Ann: Becoming a substantial holder | 28/02/19 | 0 | 381 | |||
|
|||||||
ACR | Ann: Appendix 4D and Half-Year Financial Report to 31 Dec 2018 | 17:14 | 3 | 501 | |||
|
|||||||
ACR | Ann: Appendix 3B | 18/02/19 | 0 | 168 | |||
|
|||||||
ACR | Ann: Appendix 3B | 06/02/19 | 1 | 352 | |||
|
|||||||
ACR | Ann: Acrux Receives $2.057m R&D Tax Incentive Rebate | 21/01/19 | 1 | 502 | |||
|
|||||||
ACR | Ann: Acrux confirms patent challenge for generic of efinaconazole | 28/12/18 | 19 | 6.5K | |||
|
|||||||
ACR | Ann: End of Year Update | 20/12/18 | 1 | 567 | |||
|
See All Discussions